FocusOn Healthcare
  • Women's Health
  • Bone Health
  • Urology
  • Cardiology
  • Gastroenterology
  • Neurology
  • Oncology
  • Specialties:
  • Women's Health
  • Bone Health
  • Urology
  • Cardiology
  • Head Pain
  • Gastroenterology
  • Neurology
  • Oncology

Test Your Knowledge

Urothelial Cancer Awareness Month Home Page
  1. Which of the following signs and symptoms is most commonly the initial manifestation of bladder cancer?
  2. Which of the following exposures is the leading modifiable risk factor for the development of urothelial cancer?
  3. The American Urological Association (AUA)/Society of Urologic Oncology (SUO) guidelines recommend which of the following interventions as the initial treatment for low-grade Ta bladder tumors?
  4. Patients with upper urinary tract urothelial carcinoma are at high risk for disease progression if which of the following factors are present?
  5. According to the American Urological Association (AUA) guidelines, repeat transurethral resection of high-grade Ta bladder tumors is recommended in which of the following cases?

References

  1. Gilligan TD, Steele GS, Zietman AL, et al. Signs and Symptoms. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003. Available from: https://www.ncbi.nlm.nih.gov/books/NBK13122/.
  2. PDQ Screening and Prevention Editorial Board. Bladder and Other Urothelial Cancers Screening (PDQ®): Health Professional Version. 2025 Apr 8. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.Available from: https://www.ncbi.nlm.nih.gov/books/NBK65774/.
  3. Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013;63(2):234-41.
  4. Suriano F, Altobelli E, Sergi F, Buscarini M. Bladder cancer after radiotherapy for prostate cancer. Rev Urol 2013;15(3):108-12.
  5. Holzbeierlein JM, Bixler BR, Buckley DI, et al. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment. J Urol 2024;211(4):533-538. Erratum in: J Urol 2024;212(6):936.
  6. Rouprêt M, Babjuk M, Compérat E, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. Eur Urol 2018;73(1):111-122.
  7. Cumberbatch MGK, Foerster B, Catto JWF, et al. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review. Eur Urol 2018;73(6):925-933.
FocusOn logo
  • About FocusOn
  • Privacy Policy
  • Terms of Use

© 2025 Wolters Kluwer. All right reserved.

Your Privacy

To give you the best possible experience we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, show the most relevant content, and show the most useful ads. You can select your preferences by clicking the link. For more information, please review our Privacy and Cookie Policy.

|
|

Cookie Policy

Information about our use of cookies

Wolters Kluwer ("we" or "us") wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain what personal information we collect, use and disclose.

Personal information means any data relating to an individual who can be identified, directly or indirectly, based on that information. This may include information such as names, contact details, (online) identification data, online identifiers, or other characteristics specific to that individual.

Read More